Guyon Cécile, Lussier Yoann, Bissonnette Pierre, Leduc-Nadeau Alexandre, Lonergan Michèle, Arthus Marie-Françoise, Perez Rafael Bedoya, Tiulpakov Anatoly, Lapointe Jean-Yves, Bichet Daniel G
Groupe d'Etude des Protéines Membranaires, Département de Physiologie, Université de Montréal, Montréal, Québec, Canada.
Am J Physiol Renal Physiol. 2009 Aug;297(2):F489-98. doi: 10.1152/ajprenal.90589.2008. Epub 2009 May 20.
Aquaporin-2 (AQP2) is a water channel responsible for the final water reabsorption in renal collecting ducts. Alterations in AQP2 function induce nephrogenic diabetes insipidus (NDI), a condition characterized by severe polyuria and polydipsia. Three patients affected with severe NDI, who were compound heterozygous for the AQP2 mutations D150E and G196D, are presented here along with a mildly affected D150E homozygous patient from another family. Using Xenopus oocytes as an expression system, these two mutations (G196D and D150E) were compared with the wild-type protein (AQP2-wt) for functional activity (water flux analysis), protein maturation, and plasma membrane targeting. AQP2-wt induces a major increase in water permeability (P(f) = 47.4 +/- 12.2 x 10(-4) cm/s) whereas D150E displays intermediate P(f) values (P(f) = 12.5 +/- 3.0 x 10(-4) cm/s) and G196D presents no specific water flux, similar to controls (P(f) = 2.1 +/- 0.8 x 10(-4) cm/s and 2.2 +/- 0.7 x 10(-4) cm/s, respectively). Western blot and immunocytochemical evaluations show protein targeting that parallels activity levels with AQP2-wt adequately targeted to the plasma membrane, partial targeting for D150E, and complete sequestration of G196D within intracellular compartments. When coinjecting AQP2-wt with mutants, no (AQP2-wt + D150E) or partial (AQP2-wt + G196D) reduction of water flux were observed compared with AQP2-wt alone, whereas complete loss of function was found when both mutants were coinjected. These results essentially recapitulate the clinical profiles of the family members, showing a typical dominant negative effect when G196D is coinjected with either AQP2-wt or D150E but not between AQP2-wt and D150E mutant.
水通道蛋白2(AQP2)是一种水通道,负责肾脏集合管中的最终水重吸收。AQP2功能的改变会诱发肾性尿崩症(NDI),这是一种以严重多尿和烦渴为特征的病症。本文介绍了三名患有严重NDI的患者,他们是AQP2突变D150E和G196D的复合杂合子,以及另一个家族中一名症状较轻的D150E纯合子患者。以非洲爪蟾卵母细胞作为表达系统,将这两种突变(G196D和D150E)与野生型蛋白(AQP2-wt)进行功能活性(水通量分析)、蛋白质成熟和质膜靶向方面的比较。AQP2-wt可使水通透性大幅增加(P(f) = 47.4 +/- 12.2 x 10(-4) cm/s),而D150E表现出中等的P(f)值(P(f) = 12.5 +/- 3.0 x 10(-4) cm/s),G196D则未表现出特定的水通量,与对照组相似(分别为P(f) = 2.1 +/- 0.8 x 10(-4) cm/s和2.2 +/- 0.7 x 10(-4) cm/s)。蛋白质印迹和免疫细胞化学评估显示,蛋白质靶向与活性水平平行,AQP2-wt能充分靶向到质膜,D150E部分靶向,而G196D完全隔离在细胞内区室中。当将AQP2-wt与突变体共注射时,与单独的AQP2-wt相比,未观察到水通量降低(AQP2-wt + D150E)或部分降低(AQP2-wt + G196D),而当两种突变体共注射时则发现功能完全丧失。这些结果基本上概括了家庭成员的临床特征,表明当G196D与AQP2-wt或D150E共注射时会出现典型的显性负效应,但在AQP2-wt和D150E突变体之间则不会。